Jane Street
CCXI

Jane Street’s ChemoCentryx, Inc. CCXI Stock Holding History

Jane Street’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,700
Closed -$604K – 10852
2022
Q3 		$604K Sell
11,700
-38,200
-77% -$1.58M ﹤0.01% 6335
2022
Q2 		$1.24M Sell
49,900
-106,100
-68% -$2.34M ﹤0.01% 5079
2022
Q1 		$3.91M Buy
156,000
+31,400
+25% +$882K ﹤0.01% 3462
2021
Q4 		$4.54M Sell
124,600
-209,800
-63% -$7.36M ﹤0.01% 3021
2021
Q3 		$5.72M Sell
334,400
-227,200
-40% -$3.54M ﹤0.01% 2529
2021
Q2 		$7.52M Buy
+561,600
New +$13.8M ﹤0.01% 2058
2020
Q4 		– Sell
-93,200
Closed -$5.11M – 8365
2020
Q3 		$5.11M Buy
93,200
+59,100
+173% +$3.18M ﹤0.01% 1826
2020
Q2 		$1.96M Buy
34,100
+22,000
+182% +$1.2M ﹤0.01% 3096
2020
Q1 		$486K Buy
+12,100
New +$514K ﹤0.01% 3652

Other funds holding CCXI

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Jane Street's CCXI Position: Q4 2022 in Review

Jane Street sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 7,822 shares — an estimated $404K sold.

Jane Street first reported a position in CCXI in Q4 2013 and held it in 15 quarters. The position peaked at $4.21M in Q2 2021. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Jane Street reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Jane Street sold 7,822 ChemoCentryx, Inc. shares in Q4 2022, an estimated $404K.
  • Jane Street first reported a position in ChemoCentryx, Inc. in Q4 2013 and held it in 15 quarters.
  • Jane Street's ChemoCentryx, Inc. position peaked at $4.21M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.